Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 9, 2009

Biogen Idec Taps Evotec for Hit-Identification Research

  • Evotec entered into a research agreement with Biogen Idec to find hit molecules against a target selected by Biogen Idec. The firm has the option to add more targets.

    Evotec will provide Biogen Idec with access to its full range of screening technologies and library of compounds. The company will use its background in protein production and assay development to develop new assays for the initial target.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »